Abstract:Abstract Polycystic ovary syndrome (PCOS) is a heterogeneous functional endocrine disorder associated with a low-grade, chronic inflammatory state. Patients with PCOS present an increased risk of metabolic comorbidities and often menstrual dysregulation and infertility due to anovulation and/or poor oocyte quality. Multiple mechanisms including oxidative stress and low-grade inflammation are believed to be responsible for oocyte deterioration; however, the influence of nitric oxide (NO) insufficiency in oocyte quality and ovulatory dysfunction in PCOS is still a matter for debate. Higher production of superoxide (O 2 •− ) mediated DNA damage and impaired antioxidant defense have been implicated as contributory factors for the development of PCOS, with reported alteration in superoxide dismutase (SOD) function, an imbalanced zinc/copper ratio, and increased catalase activity. These events may result in decreased hydrogen peroxide (H 2 O 2 ) accumulation with increased lipid peroxidation events. A decrease in NO, potentially due to increased activity of NO synthase (NOS) inhibitors such as asymmetric dimethylarginine (ADMA), and imbalance in the distribution of reactive oxygen species (ROS), such as decreased H 2 O 2 and increased O 2 •− , may offset the physiological processes surrounding follicular development, oocyte maturation, and ovulation contributing to the reproductive dysfunction in patients with PCOS. Thus, this proposal aims to evaluate the specific roles of NO, oxidative stress, ROS, and enzymatic and nonenzymatic elements in the pathogenesis of PCOS ovarian dysfunction, including oligo- anovulation and oocyte quality, with the intent to inspire better application of therapeutic options. The authors believe more consideration into the specific roles of oxidative stress, ROS, and enzymatic and nonenzymatic elements may allow for a more thorough understanding of PCOS. Future efforts elaborating on the role of NO in the preoptic nucleus to determine its influence on GnRH firing and follicle-stimulating hormone/Luteinizing hormone (FSH/LH) production with ovulation would be of benefit in PCOS. Consequently, treatment with an ADMA inhibitor or NO donor may prove beneficial to PCOS patients experiencing reproductive dysfunction and infertility.

Association of Free Radical Product and Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis

Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.

Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome

Oxidative stress in polycystic ovary syndrome: a case- control study

Evaluation of Oxytocin Level and Its Relationship With Oxidant-Antioxidant Status in Women With Polycystic Ovarian Syndrome

Relationship between oxidative stress and polycystic ovary syndrome in non-obese women

Relationship between Serum Levels of Oxidative Stress Markers and Metabolic Syndrome Components in PCOS Women

Polycystic ovary syndrome and its management: In view of oxidative stress

Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study

Oxidative stress and polycystic ovary syndrome: evaluation during ovarian stimulation for ICSI

Effects of vitamin D supplementation on oxidative stress biomarkers of Iranian women with polycystic ovary syndrome: a meta-analysis study

Role of Oxidative Stress in Obese and Nonobese PCOS Patients

The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality

[The effects of oxidative stress to PCOS]

The interplay between oxidative stress, zinc, and metabolic dysfunction in polycystic ovarian syndrome

A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS

Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives

Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights

The role of inflammation, oxidation and Cystatin-C in the pathophysiology of polycystic ovary syndrome